NCT03724890 2025-04-10
Study of Avelumab-M3814 Combinations
EMD Serono
Phase 1 Completed
EMD Serono
Baptist Health South Florida
University of Kentucky
Abramson Cancer Center at Penn Medicine
Icahn School of Medicine at Mount Sinai
University of Pittsburgh